NF-κB signaling pathways: Role in nervous system physiology and pathology

Neuroscientist

Volumn 19, Issue 2, 2013, Pages 175-194

  Mincheva Tasheva, Stefka ^a   Soler, Rosa M ^a  

^a Universitat de Lleida Facultat de Medicina Sabadell   (Spain)

Author keywords

Motoneuron; Neurodegenerative disorders; Neuronal survival; Neurotrophic factors; NF B; RelA p65

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROTROPHIC FACTOR; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR;

CELL SURVIVAL; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOTONEURON; NERVE CELL; NERVOUS SYSTEM; NEUROPATHOLOGY; NEUROPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL SURVIVAL; HUMANS; NERVOUS SYSTEM; NEURONS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84877824588     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858412444007     Document Type: Review

References (168)

1. Ahn HJ, Hernandez CM, Levenson JM, Lubin FD, Liou HC, Sweatt JD. 2008. c-Rel, an NF-kappaB family transcription factor, is required for hippocampal long-term synaptic plasticity and memory formation. Learn Mem 15: 539-49.
2. Airaksinen MS, Saarma M. 2002. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3: 383-94.
3. Akama KT, Albanese C, Pestell RG, Van Eldik LJ. 1998. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc Natl Acad Sci U S A 95: 5795-800.
4. Aleyasin H, Cregan SP, Iyirhiaro G, O'Hare MJ, Callaghan SM, Slack RS, and others. 2004. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage. J Neurosci 24: 2963-73.
5. Azoitei N, Wirth T, Baumann B. 2005. Activation of the IkappaB kinase complex is sufficient for neuronal differentiation of PC12 cells. J Neurochem 93: 1487-501.
6. Bae JS, Jang MK, Hong S, An WG, Choi YH, Kim HD, and others. 2003. Phosphorylation of NF-kappa B by calmodulindependent kinase IV activates anti-apoptotic gene expression. Biochem Biophys Res Commun 305: 1094-8.
7. Baeuerle PA. 1998. IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 95: 729-31.
8. Barger SW, Hörster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP. 1995. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A 92: 9328-32.
9. Baud V, Karin M. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11: 372-7.
10. Bauer MK, Lieb K, Schulze-Osthoff K, Berger M, Gebicke- Haerter PJ, Bauer J, and others. 1997. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 243: 726-31.
11. Beg AA, Baltimore D. 1996. An essential role for NFkappaB in preventing TNF-alpha-induced cell death. Science 274: 782-4.
12. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376: 167-70.
13. Beinke S, Ley SC. 2004. Functions of NF-kappaB1 and NFkappaB2 in immune cell biology. Biochem J 382: 393-409.
14. Bender K, Göttlicher M, Whiteside S, Rahmsdorf HJ, Herrlich P. 1998. Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV. EMBO J 17: 5170-81.
15. Bhattacharyya S, Borthakur A, Dudeja PK, Tobacman JK. 2010. Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations. Exp Cell Res 316: 3317-27.
16. Bockhart V, Constantin CE, Häussler A, Wijnvoord N, Kanngiesser M, Myrczek T, and others. 2009. Inhibitor kappaB kinase beta deficiency in primary nociceptive neurons increases TRP channel sensitivity. J Neurosci 29: 12919-29.
17. Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC. 2004. p53 induces NF-kappaB activation by an IkappaB kinaseindependent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem 279: 26115-25.
18. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, and others. 2004. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB: p52 dimers. EMBO J 23: 4202-10.
19. Buggia-Prevot V, Sevalle J, Rossner S, Checler F. 2008. NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. J Biol Chem 283: 10037-47.
20. Bui NT, Livolsi A, Peyron JF, Prehn JH. 2001. Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha. J Cell Biol 152: 753-64.
21. Burke MA, Bothwell M. 2003. p75 neurotrophin receptor mediates neurotrophin activation of NF-kappa B and induction of iNOS expression in P19 neurons. J Neurobiol 55: 191-203.
22. Buss H, Dörrie A, Schmitz ML, Frank R, Livingstone M, Resch K, and others. 2004. Phosphorylation of serine 468 by GSKDownloaded 3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem 279: 49571-4.
23. Cao JP, Wang HJ, Yu JK, Liu HM, Gao DS. 2008. The involvement of NF-kappaB p65/p52 in the effects of GDNF on DA neurons in early PD rats. Brain Res Bull 76: 505-11.
24. Cardoso SM, Oliveira CR. 2003. Inhibition of NF-kB renders cells more vulnerable to apoptosis induced by amyloid beta peptides. Free Radic Res 37: 967-73.
25. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhäuser N, Böhm-Matthaei R, Baeuerle PA, and others. 1996. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272: 542-5.
26. Chao MV. 2003. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4: 299-309.
27. Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, and others. 2005a. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 280: 40364-74.
28. Chen LF, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder L, and others. 2005b. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 25: 7966-75.
29. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, and others. 1995. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitinproteasome pathway. Genes Dev 9: 1586-97.
30. Cho IH, Hong J, Suh EC, Kim JH, Lee H, Lee JE, and others. 2008. Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death. Brain 131: 3019-33.
31. Chu LF, Wang WT, Ghanta VK, Lin CH, Chiang YY, Hsueh CM. 2008. Ischemic brain cell-derived conditioned medium protects astrocytes against ischemia through GDNF/ ERK/NF-kB signaling pathway. Brain Res 1239: 24-35.
32. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NFkappaB control. Proc Natl Acad Sci U S A 94: 10057-62.
33. Crosio C, Valle C, Casciati A, Iaccarino C, Carrì MT. 2011. Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS). PLoS One 6: e17187.
34. Del Signore SJ, Amante DJ, Kim J, Stack EC, Goodrich S, Cormier K, and others. 2009. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotroph Lateral Scler 10: 85-94.
35. Delhase M, Hayakawa M, Chen Y, Karin M. 1999. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284: 309-13.
36. Denis-Donini S, Dellarole A, Crociara P, Francese MT, Bortolotto V, Quadrato G, and others. 2008. Impaired adult neurogenesis associated with short-term memory defects in NF-kappaB p50-deficient mice. J Neurosci 28: 3911-9.
37. Duckworth EA, Butler T, Collier L, Collier S, Pennypacker KR. 2006. NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res 1088: 167-75.
38. Duran A, Diaz-Meco MT, Moscat J. 2003. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 22: 3910-8.
39. Ernst MK, Dunn LL, Rice NR. 1995. The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers. Mol Cell Biol 15: 872-82.
40. Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, and others. 1998. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med 187: 147-59.
41. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, and others. 1997. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 11: 3482-96.
42. Fridmacher V, Kaltschmidt B, Goudeau B, Ndiaye D, Rossi FM, Pfeiffer J, and others. 2003. Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. J Neurosci 23: 9403-8.
43. Fu ES, Zhang YP, Sagen J, Candiotti KA, Morton PD, Liebl DJ, and others. 2010. Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain 148: 509-18.
44. Gallagher D, Gutierrez H, Gavalda N, O'Keeffe G, Hay R, Davies AM. 2007. Nuclear factor-kappaB activation via tyrosine phosphorylation of inhibitor kappaB-alpha is crucial for ciliary neurotrophic factor-promoted neurite growth from developing neurons. J Neurosci 27: 9664-9.
45. Gavaldà N, Pérez-Navarro E, Gratacòs E, Comella J, Alberch J. 2004. Differential involvement of phosphatidylinositol 3-kinase and p42/p44 mitogen activated protein kinase pathways in brain-derived neurotrophic factor-induced trophic effects on cultured striatal neurons. Mol Cell Neurosci 25: 460-8.
46. Ghosh S, May MJ, Kopp EB. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-60.
47. Grilli M, Memo M. 1999. Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol 57: 1-7.
48. Grossmann M, O'Reilly LA, Gugasyan R, Strasser A, Adams JM, Gerondakis S. 2000. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J 19: 6351-60.
49. Grumont RJ, Rourke IJ, O'Reilly LA, Strasser A, Miyake K, Sha W, and others. 1998. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med 187: 663-74.
50. Gutierrez H, Davies AM. 2011. Regulation of neural process growth, elaboration and structural plasticity by NF-κB. Trends Neurosci 34: 316-25.
51. Gutierrez H, Hale VA, Dolcet X, Davies A. 2005. NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS. Development 132: 1713-26.
52. Gutierrez H, O'Keeffe GW, Gavalda N, Gallagher D, Davies AM. 2008. Nuclear factor kappa B signaling either stimulates or inhibits neurite growth depending on the phosphorylation status of p65/RelA. J Neurosci 28: 8246-56.
53. Häcker H, Karin M. 2006. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006: re13.
54. Hamanoue M, Middleton G, Wyatt S, Jaffray E, Hay RT, Davies AM. 1999. p75-mediated NF-kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor. Mol Cell Neurosci 14: 28-40.
55. Heck S, Lezoualc'h F, Engert S, Behl C. 1999. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J Biol Chem 274: 9828-35.
56. Heissmeyer V, Krappmann D, Wulczyn FG, Scheidereit C. 1999. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes. EMBO J 18: 4766-78.
57. Holley AK, Xu Y, St Clair DK, St Clair WH. 2010. RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Ann N Y Acad Sci 1201: 129-36.
58. Horwitz BH, Scott ML, Cherry SR, Bronson RT, Baltimore D. 1997. Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. Immunity 6: 765-72.
59. Huxford T, Malek S, Ghosh G. 1999. Structure and mechanism in NF-kappa B/I kappa B signaling. Cold Spring Harb Symp Quant Biol 64: 533-40.
60. Huynh QK, Boddupalli H, Rouw SA, Koboldt CM, Hall T, Sommers C, and others. 2000. Characterization of the recombinant IKK1/IKK2 heterodimer. Mechanisms regulating kinase activity. J Biol Chem 275: 25883-91.
61. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, and others. 1996. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell 86: 787-98.
62. Inta I, Paxian S, Maegele I, Zhang W, Pizzi M, Spano P, and others. 2006. Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. J Neurosci 26: 12896-903.
63. Ito CY, Kazantsev AG, Baldwin AS. 1994. Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha. Nucleic Acids Res 22: 3787-92.
64. Jacque E, Tchenio T, Piton G, Romeo PH, Baud V. 2005. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc Natl Acad Sci U S A 102: 14635-40.
65. Kaltschmidt B, Heinrich M, Kaltschmidt C. 2002. Stimulusdependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells. Neuromolecular Med 2: 299-309.
66. Kaltschmidt B, Kaltschmidt C. 2009. NF-kappaB in the nervous system. Cold Spring Harb Perspect Biol 1: a001271.
67. Kaltschmidt B, Widera D, Kaltschmidt C. 2005. Signaling via NF-kappaB in the nervous system. Biochim Biophys Acta 1745: 287-99.
68. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. 1997. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A 94: 2642-7.
69. Kaltschmidt B, Uherek M, Wellmann H, Volk B, Kaltschmidt C. 1999. Inhibition of NF-kappaB potentiates amyloid betamediated neuronal apoptosis. Proc Natl Acad Sci U S A 96: 9409-14.
70. Kaltschmidt B, Kaltschmidt C, Hofmann TG, Hehner SP, Dröge W, Schmitz ML. 2000. The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur J Biochem 267: 3828-35.
71. Kaltschmidt B, Ndiaye D, Korte M, Pothion S, Arbibe L, Prüllage M, and others. 2006. NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling. Mol Cell Biol 26: 2936-46.
72. Kaltschmidt C, Kaltschmidt B, Baeuerle PA. 1993. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech Dev 43: 135-47.
73. Kato T Jr, Delhase M, Hoffmann A, Karin M. 2003. CK2 is a C-terminal IkappaB kinase responsible for NF-kappaB activation during the UV response. Mol Cell 12: 829-39.
74. Khorooshi R, Babcock AA, Owens T. 2008. NF-kappaB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J Immunol 181: 7284-91.
75. Khoshnan A, Ko J, Tescu S, Brundin P, Patterson PH. 2009. IKKalpha and IKKbeta regulation of DNA damage-induced cleavage of huntingtin. PLoS One 4: e5768.
76. Khoshnan A, Ko J, Watkin EE, Paige LA, Reinhart PH, Patterson PH. 2004. Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J Neurosci 24: 7999-8008.
77. Kiernan R, Brès V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, and others. 2003. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 278: 2758-66.
78. Kim S, La Motte-Mohs RN, Rudolph D, Zuniga-Pflucker JC, Mak TW. 2003. The role of nuclear factor-kappaB essential modulator (NEMO) in B cell development and survival. Proc Natl Acad Sci U S A 100: 1203-8.
79. Kitaoka Y, Kumai T, Lam TT, Munemasa Y, Isenoumi K, Motoki M, and others. 2004. Nuclear factor-kappa B p65 in NMDA-induced retinal neurotoxicity. Brain Res Mol Brain Res 131: 8-16.
80. Köntgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, and others. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 9: 1965-77.
81. Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS. 2010. Nuclear factor-kappaB is a critical mediator of stressimpaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A 107: 2669-74.
82. Kwak YT, Guo J, Shen J, Gaynor RB. 2000. Analysis of domains in the IKKalpha and IKKbeta proteins that regulate their kinase activity. J Biol Chem 275: 14752-9.
83. Lam LT, Davis RE, Ngo VN, Lenz G, Wright G, Xu W, and others. 2008. Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen. Proc Natl Acad Sci U S A 105: 20798-803.
84. Lee HJ, Kim SH, Kim KW, Um JH, Lee HW, Chung BS, and others. 2001. Antiapoptotic role of NF-kappaB in the autooxidized dopamine-induced apoptosis of PC12 cells. J Neurochem 76: 602-9.
85. Li LY, Zhao XL, Fei XF, Gu ZL, Qin ZH, Liang ZQ. 2008. Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra. Acta Pharmacol Sin 29: 539-47.
86. Li Q, Estepa G, Memet S, Israel A, Verma IM. 2000. Complete lack of NF-kappaB activity in IKK1 and IKK2 doubledeficient mice: additional defect in neurulation. Genes Dev 14: 1729-33.
87. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC, and others. 1999b. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 13: 1322-8.
88. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. 1999a. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284: 321-5.
89. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, and others. 1999c. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189: 1839-45.
90. Li ZW, Omori SA, Labuda T, Karin M, Rickert RC. 2003. IKK beta is required for peripheral B cell survival and proliferation. J Immunol 170: 4630-7.
91. Liang ZQ, Wang X, Li LY, Wang Y, Chen RW, Chuang DM, and others. 2007. Nuclear factor-kappaB-dependent cyclin D1 induction and DNA replication associated with N-methyl- D-aspartate receptor-mediated apoptosis in rat striatum. J Neurosci Res 85: 1295-309.
92. Lo JC, Basak S, James ES, Quiambo RS, Kinsella MC, Alegre ML, and others. 2006. Coordination between NFkappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues. Blood 107: 1048-55.
93. Lu Z, Yu S, Wei J, Wei L. 2006. Age-related neural degeneration in nuclear-factor kappaB p50 knockout mice. Neuroscience 139: 965-78.
94. Maehara K, Hasegawa T, Isobe KI. 2000. A NF-kappaB p65 subunit is indispensable for activating manganese superoxide: dismutase gene transcription mediated by tumor necrosis factor-alpha. J Cell Biochem 77: 474-86.
95. Mattson MP, Camandola S. 2001. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107: 247-54.
96. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D. 2003. NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 6: 1072-8.
97. Meunier A, Latrémolière A, Dominguez E, Mauborgne A, Philippe S, Hamon M, and others. 2007. Lentiviralmediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. Mol Ther 15: 687-97.
98. Middleton G, Hamanoue M, Enokido Y, Wyatt S, Pennica D, Jaffray E, and others. 2000. Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol 148: 325-32.
99. Middleton G, Wyatt S, Ninkina N, Davies AM. 2001. Reciprocal developmental changes in the roles of Bcl-w and Bclx( L) in regulating sensory neuron survival. Development 128: 447-57.
100. Migheli A, Piva R, Atzori C, Troost D, Schiffer D. 1997. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 56: 1314-22.
101. Mincheva S, Garcera A, Gou-Fabregas M, Encinas M, Dolcet X, Soler RM. 2011. The canonical nuclear factor-kappaB pathway regulates cell survival in a developmental model of spinal cord motoneurons. J Neurosci 31: 6493-503.
102. Mir M, Tolosa L, Asensio VJ, Lladó J, Olmos G. 2008. Complementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generation. J Neuroimmunol 204: 101-9.
103. Müller JR, Siebenlist U. 2003. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J Biol Chem 278: 12006-12.
104. Nakai M, Qin ZH, Chen JF, Wang Y, Chase TN. 2000. Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation. J Neurochem 74: 647-58.
105. Nakajima K, Kohsaka S. 1998. Functional roles of microglia in the central nervous system. Hum Cell 11: 141-55.
106. Nickols JC, Valentine W, Kanwal S, Carter BD. 2003. Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat Neurosci 6: 161-7.
107. Niu YL, Zhang WJ, Wu P, Liu B, Sun GT, Yu DM, and others. 2010. Expression of the apoptosis-related proteins caspase-3 and NF-kappaB in the hippocampus of Tg2576 mice. Neurosci Bull 26: 37-46.
108. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, and others. 2004. Nuclear factorkappaB contributes to infarction after permanent focal ischemia. Stroke 35: 987-91.
109. Olson CM, Hedrick MN, Izadi H, Bates TC, Olivera ER, Anguita J. 2007. p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens. Infect Immun 75: 270-7.
110. Panet H, Barzilai A, Daily D, Melamed E, Offen D. 2001. Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells. J Neurochem 77: 391-8.
111. Paris D, Patel N, Quadros A, Linan M, Bakshi P, Ait-Ghezala G, and others. 2007. Inhibition of Abeta production by NFkappaB inhibitors. Neurosci Lett 415: 11-6.
112. Perkins ND. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62.
113. Pizzi M, Goffi F, Boroni F, Benarese M, Perkins SE, Liou HC, and others. 2002. Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta. J Biol Chem 277: 20717-23.
114. Place RF, Haspeslagh D, Hubbard AK, Giardina C. 2001. Cytokine- induced stabilization of newly synthesized I(kappa) B-alpha. Biochem Biophys Res Commun 283: 813-20.
115. Pyo JS, Ko YS, Kim WH, Kim M, Lee KW, Nam SY, and others. 2010. Impairment of nuclear factor-kappaB activation increased glutamate excitotoxicity in a motoneuronneuroblastoma hybrid cell line expressing mutant (G93A) Cu/Zn-superoxide dismutase. J Neurosci Res 88: 2494-503.
116. Qin ZH, Chen RW, Wang Y, Nakai M, Chuang DM, Chase TN. 1999. Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptormediated apoptosis in rat striatum. J Neurosci 19: 4023-33.
117. Rojo AI, Salinas M, Martín D, Perona R, Cuadrado A. 2004. Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J Neurosci 24: 7324-34.
118. Rothgiesser KM, Erener S, Waibel S, Lüscher B, Hottiger MO. 2010b. SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310. J Cell Sci 123: 4251-8.
119. Rothgiesser KM, Fey M, Hottiger MO. 2010a. Acetylation of p65 at lysine 314 is important for late NF-kappaB-dependent gene expression. BMC Genomics 11: 22.
120. Rudolph D, Yeh W, Wakeham A, Rudolph B, Nallainathan D, Potter J, and others. 2000. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgammadeficient mice. Genes Dev 14: 854-62.
121. Ryu H, Smith K, Camelo SI, Carreras I, Lee J, Iglesias AH, and others. 2005. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J Neurochem 93: 1087-98.
122. Saha RN, Liu X, Pahan K. 2006. Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol 1: 212-22.
123. Sanchez-Ponce D, Muñoz A, Garrido JJ. 2011. Casein kinase 2 and microtubules control axon initial segment formation. Mol Cell Neurosci 46: 222-34.
124. Sarnico I, Lanzillotta A, Boroni F, Benarese M, Alghisi M, Schwaninger M, and others. 2009. NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. J Neurochem 108: 475-85.
125. Schmidt-Ullrich R, Mémet S, Lilienbaum A, Feuillard J, Raphaël M, Israel A. 1996. NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. Development 122: 2117-28.
126. Schwabe RF, Brenner DA. 2002. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. Am J Physiol Gastrointest Liver Physiol 283: G204-G211.
127. Schwaninger M, Inta I, Herrmann O. 2006. NF-kappaB signalling in cerebral ischaemia. Biochem Soc Trans 34: 1291-4.
128. Schwarz EM, Van Antwerp D, Verma IM. 1996. Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha. Mol Cell Biol 16: 3554-9.
129. Sen R, Baltimore D. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-16.
130. Sha WC, Liou HC, Tuomanen EI, Baltimore D. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80: 321-30.
131. Shang YC, Chong ZZ, Hou J, Maiese K. 2010. Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress. Cell Signal 22: 1317-29.
132. Shou Y, Li N, Li L, Borowitz JL, Isom GE. 2002. NF-kappaBmediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis. J Neurochem 81: 842-52.
133. Simpson CS, Morris BJ. 2000. Regulation of neuronal cell adhesion molecule expression by NF-kappa B. J Biol Chem 275: 16879-84.
134. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR. 2002. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J Biol Chem 277: 3863-69.
135. Smith D, Tweed C, Fernyhough P, Glazner GW. 2009. Nuclear factor-kappaB activation in axons and Schwann cells in experimental sciatic nerve injury and its role in modulating axon regeneration: studies with etanercept. J Neuropathol Exp Neurol 68: 691-700.
136. Sole C, Dolcet X, Segura MF, Gutierrez H, Diaz-Meco MT, Gozzelino R, and others. 2004. The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-kapp B signaling. J Cell Biol 167: 479-92.
137. Solt LA, Madge LA, Orange JS, May MJ. 2007. Interleukin- 1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta. J Biol Chem 282: 8724-33.
138. Sparacio SM, Zhang Y, Vilcek J, Benveniste EN. 1992. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein. J Neuroimmunol 39: 231-42.
139. Stephenson D, Yin T, Smalstig EB, Hsu MA, Panetta J, Little S, and others. 2000. Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. J Cereb Blood Flow Metab 20: 592-603.
140. Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, Aggarwal BB. 2003. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk proteintyrosine kinase. J Biol Chem 278: 24233-41.
141. Takano H, Gusella JF. 2002. The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor. BMC Neurosci 3: 15.
142. Tam WF, Lee LH, Davis L, Sen R. 2000. Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1- dependent nuclear export. Mol Cell Biol 20: 2269-84.
143. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, and others. 1999. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 274: 8531-8.
144. Taylor DL, Jones F, Kubota ES, Pocock JM. 2005. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 25: 2952-64.
145. Tolosa L, Caraballo-Miralles V, Olmos G, Lladó J. 2011. TNF- α potentiates glutamate-induced spinal cord motoneuron death via NF-κB. Mol Cell Neurosci 46: 176-86.
146. Valerio A, Boroni F, Benarese M, Sarnico I, Ghisi V, Bresciani LG, and others. 2006. NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production. Eur J Neurosci 23: 1711-20.
147. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G. 2003. Transcriptional activation of the NFkappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22: 1313-24.
148. Vollgraf U, Wegner M, Richter-Landsberg C. 1999. Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem 73: 2501-9.
149. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. 1998. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-3.
150. Wang D, Westerheide SD, Hanson JL, Baldwin AS Jr. 2000 Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 275: 32592-7.
151. Wei X, Zhang X, Flick LM, Drissi H, Schwarz EM, O'Keefe RJ. 2009. Titanium particles stimulate COX-2 expression in synovial fibroblasts through an oxidative stress-induced, calpain-dependent, NF-kappaB pathway. Am J Physiol Cell Physiol 297: C310-320.
152. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, and others. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 80: 331-40.
153. Weih F, Durham SK, Barton DS, Sha WC, Baltimore D, Bravo R. 1997. p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice. J Exp Med 185: 1359-70.
154. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. 1997. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278: 866-9.
155. Wu H, Lozano G. 1994. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 269: 20067-74.
156. Xie QW, Kashiwabara Y, Nathan C. 1994. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-8.
157. Xu J, Chen S, Ahmed SH, Chen H, Ku G, Goldberg MP, and others. 2001. Amyloid-beta peptides are cytotoxic to oligodendrocytes. J Neurosci 21: RC118.
158. Xu W, Chi L, Xu R, Ke Y, Luo C, Cai J, and others. 2005. Increased production of reactive oxygen species contributes to motor neuron death in a compression mouse model of spinal cord injury. Spinal Cord 43: 204-13.
159. Xu Z, Chen S, Li X, Luo G, Li L, Le W. 2006. Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res 31: 1263-9.
160. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB. 2003. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423: 655-9.
161. Yeo W, Gautier J. 2004. Early neural cell death: dying to become neurons. Dev Biol 274: 233-44.
162. Yilmaz ZB, Weih DS, Sivakumar V, Weih F. 2003. RelB is required for Peyer's patch development: differential regulation of p52- RelB by lymphotoxin and TNF. EMBO J 22: 121-30.
163. Yoon C, Korade Z, Carter BD. 2008. Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factorkappaB promotes Schwann cell differentiation into a myelinating phenotype. J Neurosci 28: 3738-46.
164. Yu Z, Zhou D, Bruce-Keller AJ, Kindy MS, Mattson MP. 1999. Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J Neurosci 19: 8856-65.
165. Yu Z, Zhou D, Cheng G, Mattson MP. 2000. Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease. J Mol Neurosci 15: 31-44.
166. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. 1997. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91: 243-52.
167. Zhang J, Warren MA, Shoemaker SF, Ip MM. 2007. NFkappaB1/ p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB. Endocrinology 148: 268-78.
168. Zhong H, Voll RE, Ghosh S. 1998. Phosphorylation of NFkappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1: 661-71.